Anuh Pharma Ltd: Stock Analysis & Fundamentals

Updated this week

Anuh Pharma Ltd (Pharma - API) — fundamental analysis, earnings data, and key metrics. PE: 16.8. ROE: 13.4%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

💪Debt reduced 100% YoY — balance sheet strengthening

👔Promoter buying — stake up 1.9% this quarter

Key Numbers

Current Price

₹70

Dividend Yield

2.13%

Market Cap

704 Cr

Valuation

N/A

Other Top Pharma - API Stocks Beating Nifty 500

Senores Pharmaceuticals Ltd

Average

+8.4%

Ind-Swift Laboratories Ltd

← Back to Pharma - API Dashboard

Frequently Asked Questions: Anuh Pharma Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Anuh Pharma Ltd's latest quarterly results?

Anuh Pharma Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: +30.0%
Revenue Growth YoY: +23.1%
Operating Margin: 9.0%

What is Anuh Pharma Ltd's current PE ratio?

Anuh Pharma Ltd's current PE ratio is 16.8x.

Current PE: 16.8x
Market Cap: 704 Cr
Dividend Yield: 2.13%

What is Anuh Pharma Ltd's price-to-book ratio?

Anuh Pharma Ltd's price-to-book ratio is 2.2x.

Price-to-Book (P/B): 2.2x
Book Value per Share: ₹33
Current Price: ₹70

Is Anuh Pharma Ltd a fundamentally strong company?

Anuh Pharma Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 17.0%

Is Anuh Pharma Ltd debt free?

Anuh Pharma Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹11 Cr

What is Anuh Pharma Ltd's return on equity (ROE) and ROCE?

Anuh Pharma Ltd's return ratios over recent years

FY2023: ROCE 19.0%
FY2024: ROCE 26.0%
FY2025: ROCE 17.0%

Is Anuh Pharma Ltd's cash flow positive?

Anuh Pharma Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹37 Cr
Free Cash Flow (FCF): ₹17 Cr
CFO/PAT Ratio: 79% (adequate)

What is Anuh Pharma Ltd's dividend yield?

Anuh Pharma Ltd's current dividend yield is 2.13%.

Dividend Yield: 2.13%
Current Price: ₹70

Who holds Anuh Pharma Ltd shares — promoters, FII, DII?

Anuh Pharma Ltd's shareholding pattern (Dec 2025)

Promoters: 71.8%
FII (Foreign): 0.0%
DII (Domestic): 0.0%
Public: 28.2%

Is promoter holding increasing or decreasing in Anuh Pharma Ltd?

Anuh Pharma Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 71.8% (Dec 2025)
Previous Quarter: 71.8% (Sep 2025)
Change: 0.00% (stable)

Is Anuh Pharma Ltd a new momentum entry or an established outperformer?

Anuh Pharma Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Anuh Pharma Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Anuh Pharma Ltd may be worth studying

Cash flow is positive — CFO ₹37 Cr

What is the investment thesis for Anuh Pharma Ltd?

Anuh Pharma Ltd investment thesis summary:

What is the future outlook for Anuh Pharma Ltd?

Anuh Pharma Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.